Canton Strategic Holdings (CNTN) Shares Outstanding (2020 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Shares Outstanding (Entity) came in at $207.7 million in Q1 2026, up 9748.55% YoY from $2.1 million in Q1 2025, and up 459.67% on a QoQ basis from $37.1 million in Q4 2025.

Canton Strategic Holdings (CNTN) Shares Outstanding (2020 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 7 years of Shares Outstanding (Entity) data on file, last reported at $207.7 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 9748.55% year-over-year to $207.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $207.7 million (up 9748.55% YoY) and the FY2025 annual result came in at $37.1 million, up 2762.98% from the prior year.
  • Shares Outstanding (Entity) improved to $207.7 million in Q1 2026, from $37.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $207.7 million in Q1 2026 to a low of $1.1 million in Q2 2024.
  • A 5-year average of $21.5 million and a median of $11.6 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) plunged 93.52% — and 2026, when it soared 9748.55%.
  • Tracing CNTN's Shares Outstanding (Entity) over 5 years: stood at $11.6 million in 2022, then sank by 88.75% to $1.3 million in 2023, then retreated by 0.7% to $1.3 million in 2024, then surged by 2762.98% to $37.1 million in 2025, then soared by 459.67% to $207.7 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $207.7 million (Q1 2026), $37.1 million (Q4 2025), and $7.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Canton Strategic Holdings 419.57 Mn 419.57 Mn - 207.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 207.71 Mn
Dec 31, 2025 32.05 Mn
Sep 30, 2025 6.24 Mn
Jun 30, 2025 2.88 Mn
Mar 31, 2025 2.57 Mn
Dec 31, 2024 1.30 Mn
Sep 30, 2024 1.55 Mn
Jun 30, 2024 962,149.00
Mar 31, 2024 11.76 Mn
Dec 31, 2023 1.31 Mn
Sep 30, 2023 17.29 Mn
Jun 30, 2023 14.95 Mn
Mar 31, 2023 11.51 Mn
Dec 31, 2022 11.32 Mn
Sep 30, 2022 11.53 Mn
Jun 30, 2022 11.57 Mn
Mar 31, 2022 10.57 Mn
Dec 31, 2021 6.36 Mn
Sep 30, 2021 6.36 Mn
Jun 30, 2021 6.36 Mn